Michael Dial, PhD


Prior to joining Hatteras, Mike was a Vice President in Silicon Valley Bank’s Corporate Finance Group where he focused on emerging life science companies and venture capital funds. Prior to SVB, he held research scientist positions in the Department of Biochemistry at UNC-Chapel Hill, the Laboratory of Structural Biology at the National Institute of Environmental Health Sciences, and the UNC-Duke Michael Hooker Proteomics Center. He has performed research in the fields of cell cycle regulation, proteomics, and cancer therapy.

Mike is a Professor of the Practice at the Kenan-Flagler Business School at The University of North Carolina at Chapel Hill and is also the Manager of the Carolina Research Ventures Fund, a fund dedicated to UNC-Chapel Hill related start-ups. He holds a Ph.D. in Biochemistry and Biophysics from UNC-Chapel Hill.


Mike serves on the boards of Genturi and StrideBio and is a board observer at Spyryx. Mike has also served on various committees and panels for the North Carolina Biotech Center, Council for Entrepreneurial Development, SEBIO, PTP NEXT and Durham’s Partnership for Children.